Literature DB >> 12035943

Testosterone acts as a coronary vasodilator by a calcium antagonistic action.

K M English1, R D Jones, T H Jones, A H Morice, K S Channer.   

Abstract

T acts as a vasodilator in vitro and in vivo. Supplemental T therapy in humans with angina improves symptoms and reduces objective measures of ischemia. In left anterior descending coronary arteries taken from adult male Wistar rats, T abolishes 100+/-4.2% of calcium-dependent contraction induced by potassium chloride, 82.3+/-6.1% of the mostly calcium-dependent contraction induced by prostaglandin-F-2-alpha, but only 45.3+/-3.4% of the contraction induced by phorbol-12,13-dibutyrate (PDBu) in the presence of extracellular calcium, and 54.5+/-4.5% of the contraction induced by PDBu in the absence of extracellular calcium. These findings suggest that T is primarily inhibiting the calcium-dependent elements of vascular contraction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12035943     DOI: 10.1007/BF03344037

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  9 in total

1.  Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study.

Authors:  K M English; R P Steeds; T H Jones; M J Diver; K S Channer
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

2.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

Authors:  M J Mulvany; W Halpern
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

3.  Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo.

Authors:  T M Chou; K Sudhir; S J Hutchison; E Ko; T M Amidon; P Collins; K Chatterjee
Journal:  Circulation       Date:  1996-11-15       Impact factor: 29.690

4.  Decreased [Ca(2+)](i) during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone.

Authors:  J G Murphy; R A Khalil
Journal:  J Pharmacol Exp Ther       Date:  1999-10       Impact factor: 4.030

5.  Gender-specific inhibition of Ca2+ entry mechanisms of arterial vasoconstriction by sex hormones.

Authors:  J K Crews; R A Khalil
Journal:  Clin Exp Pharmacol Physiol       Date:  1999-09       Impact factor: 2.557

6.  Acute anti-ischemic effect of testosterone in men with coronary artery disease.

Authors:  G M Rosano; F Leonardo; P Pagnotta; F Pelliccia; G Panina; E Cerquetani; P L della Monica; B Bonfigli; M Volpe; S L Chierchia
Journal:  Circulation       Date:  1999-04-06       Impact factor: 29.690

7.  Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease.

Authors:  C M Webb; J G McNeill; C S Hayward; D de Zeigler; P Collins
Journal:  Circulation       Date:  1999-10-19       Impact factor: 29.690

8.  Phorbol 12,13-dibutyrate increases vascular tone but has a dual action on intracellular calcium levels in porcine coronary arteries.

Authors:  T Mori; T Yanagisawa; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

9.  Testosterone relaxes rabbit coronary arteries and aorta.

Authors:  P Yue; K Chatterjee; C Beale; P A Poole-Wilson; P Collins
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

  9 in total
  26 in total

1.  Cardiovascular effects of testosterone: implications of the "male menopause"?

Authors:  K S Channer; T H Jones
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

Review 2.  The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?

Authors:  Richard D Jones; Peter J Pugh; T Hugh Jones; Kevin S Channer
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

3.  The vasodilatory effect of testosterone on renal afferent arterioles.

Authors:  Yan Lu; Yiling Fu; Ying Ge; Luis A Juncos; Jane F Reckelhoff; Ruisheng Liu
Journal:  Gend Med       Date:  2012-03-22

Review 4.  Testosterone Replacement Therapy and Mortality in Older Men.

Authors:  G I Hackett
Journal:  Drug Saf       Date:  2016-02       Impact factor: 5.606

Review 5.  Anabolic androgenic steroids and intracellular calcium signaling: a mini review on mechanisms and physiological implications.

Authors:  J M Vicencio; M Estrada; D Galvis; R Bravo; A E Contreras; D Rotter; G Szabadkai; J A Hill; B A Rothermel; E Jaimovich; S Lavandero
Journal:  Mini Rev Med Chem       Date:  2011-05       Impact factor: 3.862

6.  Testosterone and insulin resistance in the metabolic syndrome and T2DM in men.

Authors:  Preethi M Rao; Daniel M Kelly; T Hugh Jones
Journal:  Nat Rev Endocrinol       Date:  2013-06-25       Impact factor: 43.330

7.  Testosterone-induced relaxation of coronary arteries: activation of BKCa channels via the cGMP-dependent protein kinase.

Authors:  Viju Deenadayalu; Yashoda Puttabyatappa; Alexander T Liu; John N Stallone; Richard E White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-11       Impact factor: 4.733

Review 8.  Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.

Authors:  C Cattabiani; S Basaria; G P Ceda; M Luci; A Vignali; F Lauretani; G Valenti; R Volpi; M Maggio
Journal:  J Endocrinol Invest       Date:  2011-11-08       Impact factor: 4.256

9.  Nonlinear association between serum testosterone levels and coronary artery disease in Iranian men.

Authors:  Nader Fallah; Kazem Mohammad; Keramat Nourijelyani; Mohammad Reza Eshraghian; Seyyed Ali Seyyedsalehi; Maria Raiessi; Maziar Rahmani; Hamid Reza Goodarzi; Soodabeh Darvish; Hojjat Zeraati; Gholamreza Davoodi; Saeed Sadeghian
Journal:  Eur J Epidemiol       Date:  2009-04-09       Impact factor: 8.082

10.  Peroxynitrite mediates testosterone-induced vasodilation of microvascular resistance vessels.

Authors:  Yashoda Puttabyatappa; John N Stallone; Adviye Ergul; Azza B El-Remessy; Sanjiv Kumar; Stephen Black; Maribeth Johnson; Mary P Owen; Richard E White
Journal:  J Pharmacol Exp Ther       Date:  2013-01-14       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.